ImmunoTargets and Therapy
Impact Factor Trend (2023–2026)
Clarivate IF trend for ImmunoTargets and Therapy
SCImago Journal Rank citation prestige weighting
36 papers with at least that number of citations each
Aims & Scope
ImmunoTargets and Therapy is an international, peer-reviewed open access journal focusing on the immunological basis of diseases, potential targets for immune based therapy and treatment protocols employed to improve patient management. Basic immunology and physiology of the immune system in health, and disease will be also covered. In addition, the journal will focus on the impact of management programs and new therapeutic agents and protocols on patient perspectives such as quality of life, adherence and satisfaction. This journal explores the evidence behind new and existing therapies in terms of improving outcomes and, importantly, will seek to define their usage in terms of ultimate uptake and acceptance by the patient and health care professional. As of 1st April 2019, ImmunoTargets and Therapy will no longer consider meta-analyses for publication.
Special Issues
Calls for PapersNo active Calls for Papers found for this journal.
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
IMMUNOLOGY
IMMUNOLOGY
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Journal Metrics & Citation Visualizations
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Academic Intelligence Overview & Context
ImpaQ AnalysisImmunoTargets and Therapy is a peer-reviewed international scholarly journal in the field of IMMUNOLOGY, published by Dove Medical Press in United Kingdom. The periodical holds a Journal Impact Factor (JIF) of 4.10, ranking in quartile Q2 of Web of Science (ESCI), a Scopus SJR indicator of 1.110 (Q2), an H-index of 36.
The journal enforces rigorous peer evaluation with an annual output of approximately 30 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,712 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics